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The emergence of industrial biotechnology projects in the last years has created 
the need to accelerate the tasks of strain development, as most strains have naturally 
evolved for growth and not for the production of desired compounds. Moreover, in many 
cases, microbial strains are being used to produce compounds that are not native to their 
metabolism, requiring the addition of heterologous genes.  
Thus, concurrently with fast and novel developments in molecular biology, there 
has been a significant investment in modelling and computational tools to aid rational strain 
design efforts. In our research group at Minho University, Portugal, we have been involved 
in several projects where relevant tools such as OptGene [1] have been developed and were 
responsible for launching a user-friendly, widely used software tool in metabolic 
engineering projects: the OptFlux [2] platform. More recently, we have also launched the 
merlin tool [3] for aiding in genome-scale model reconstruction processes. 
Based on the knowledge accumulated in the in silico metabolic engineering field, 
the spinoff company SilicoLife was launched in 2010 to answer some market needs that 
could not have been addressed through the University. SilicoLife is now a fully 
independent company specialized in designing in silico metabolic engineering solutions for 
industrial biotechnology, having projects with some of the major players in the field 
worldwide, both from industry and academia. SilicoLife has several proprietary 
technologies, from a pipeline for microbial model reconstruction to tools that aid the 
identification of non-trivial interventions such as gene knockouts and 
over/underexpressions for re-directing the metabolic fluxes to the desired target. More 
recently, SilicoLife has developed a novel framework, called NeoSynth, to aid in synthetic 
biology projects allowing to enumerate potentially novel enzymatic steps, making use of 
enzyme promiscuity or through enzyme engineering.  
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